Waystar Holding Corp. (NASDAQ:WAY) Receives $36.14 Average Target Price from Analysts

Shares of Waystar Holding Corp. (NASDAQ:WAY) have earned an average rating of “Buy” from the twenty-three brokerages that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, seventeen have issued a buy recommendation and three have given a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $36.1429.

Several research firms have recently issued reports on WAY. Freedom Capital upgraded Waystar from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 18th. Canaccord Genuity Group cut their price objective on Waystar from $54.00 to $30.00 and set a “buy” rating on the stock in a report on Wednesday, February 18th. JPMorgan Chase & Co. cut their price objective on Waystar from $40.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Deutsche Bank Aktiengesellschaft cut their price objective on Waystar from $42.00 to $37.00 and set a “buy” rating on the stock in a report on Thursday, March 12th. Finally, Evercore set a $27.00 price objective on Waystar in a report on Wednesday, February 18th.

Waystar Price Performance

Waystar stock opened at $19.39 on Friday. The firm has a market capitalization of $3.72 billion, a P/E ratio of 28.94, a PEG ratio of 0.79 and a beta of 0.21. Waystar has a 1 year low of $19.37 and a 1 year high of $41.49. The business has a 50-day moving average of $23.99 and a 200-day moving average of $28.94. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37.

Waystar (NASDAQ:WAY) last posted its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.03. The company had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, equities analysts anticipate that Waystar will post 1.45 EPS for the current year.

Hedge Funds Weigh In On Waystar

Several institutional investors have recently modified their holdings of WAY. Root Financial Partners LLC lifted its holdings in shares of Waystar by 6,475.0% during the 1st quarter. Root Financial Partners LLC now owns 1,052 shares of the company’s stock valued at $25,000 after purchasing an additional 1,036 shares in the last quarter. ANTIPODES PARTNERS Ltd lifted its stake in Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after acquiring an additional 449 shares in the last quarter. First Horizon Corp bought a new stake in Waystar in the 3rd quarter valued at approximately $38,000. Smartleaf Asset Management LLC lifted its stake in Waystar by 6,005.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company’s stock valued at $38,000 after acquiring an additional 1,141 shares in the last quarter. Finally, Danske Bank A S bought a new stake in Waystar in the 4th quarter valued at approximately $52,000.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.